@article{Ashish B Shah_Gupta_2021, title={Comparison Between the Intravenous Ramosetron and Ondansetron in Prevention of Post-Operative Vomiting and Nausea in Adults Under General Anesthesia}, volume={6}, url={https://aijournals.com/index.php/aan/article/view/2206}, abstractNote={<p><strong>Background: </strong>Present study was performed as randomized controlled trial to contrast the therapeutic efficiency of ramosetron and ondansetron for the management of recognized PONV in Subjects subsequent surgery under general anesthesia. <strong>Subjects and Methods: </strong>The Subjects will be separated into 2 groups of 100 each, in a random, single blinded mode. Group I received Ramosetron 0.3 mg I.V and Group II received Ondansetron 4 mg I.V. Postoperatively, Subjects were calculated for episodes of nausea, retching and vomiting and the need for rescue antiemetic at intervals of 0-2 hours, 2 -12 hours, 12 - 24 hours and 24 - 48 hours. <strong>Results: </strong>In this study, complete response was noted to be 60% in the Ondansetron group and 82% in the Ramosetron group. The requirement of rescue medication was less in the Ramosetron group compared to the Ondansetron group (2% vs. 14%). <strong>Conclusion: </strong>It is concluded from this study that Ramosetron 0.3 mg is safe and well-tolerated and additional effectual than Ondansetron 4 mg in the prevention of postoperative nausea and vomiting.</p&gt;}, number={2}, journal={Academia Anesthesiologica International}, author={Ashish B Shah and Gupta, Richa}, year={2021}, month={Dec.}, pages={54-58} }